Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.99 USD | -0.87% | +4.72% | +22.92% |
Apr. 30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
Apr. 29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
Financials (USD)
Sales 2024 * | 139M | Sales 2025 * | 164M | Capitalization | 507M |
---|---|---|---|---|---|
Net income 2024 * | -20M | Net income 2025 * | -11M | EV / Sales 2024 * | 3.65 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.09 x |
P/E ratio 2024 * |
-25.2
x | P/E ratio 2025 * |
-42.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.93% |
Latest transcript on Avid Bioservices, Inc.
1 day | -0.87% | ||
1 week | +4.72% | ||
Current month | -1.24% | ||
1 month | -7.84% | ||
3 months | +22.92% | ||
6 months | +58.53% | ||
Current year | +22.92% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Green
CEO | Chief Executive Officer | 60 | 20-07-29 |
Daniel Hart
DFI | Director of Finance/CFO | 50 | 18-07-31 |
Nick Ferguson
CTO | Chief Tech/Sci/R&D Officer | - | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Sargen
BRD | Director/Board Member | 58 | 17-11-26 |
Joseph Carleone
CHM | Chairman | 78 | 17-11-26 |
Catherine Mackey
BRD | Director/Board Member | 68 | 19-07-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 7.99 | -0.87% | 583,498 |
24-06-10 | 8.06 | +1.26% | 1,083,239 |
24-06-07 | 7.96 | -0.87% | 405,667 |
24-06-06 | 8.03 | -3.02% | 622,400 |
24-06-05 | 8.28 | +8.52% | 771,023 |
Delayed Quote Nasdaq, June 11, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.92% | 512M | |
-0.46% | 92.26B | |
-2.63% | 38.11B | |
-12.76% | 32.9B | |
+66.54% | 26.51B | |
-13.02% | 15.75B | |
-5.27% | 13.36B | |
-10.50% | 11.65B | |
-49.11% | 10.12B | |
+187.82% | 9.78B |
- Stock Market
- Equities
- CDMO Stock